Nature, Vol.548, No.7668, 398-400, 2017
BIOTECHNOLOGY At the heart of gene edits in human embryos
The gene-editing technology CRISPR-Cas has been used in human embryos grown in vitro to correct a disease-associated mutation. The introduction of editing components at fertilization aided repair efficiency. SEE ARTICLE P.413